Different brain areas seem to be involved in the cardiovascular responses to stress. The medial amygdala (MeA) has been shown to participate in cardiovascular control, and acute stress activates the MeA to a greater extent than any of the other amygdaloid structures. It has been demonstrated that the brain histaminergic system may be involved in behavioral, autonomic and neuroendocrine responses to stressful situations. The aim of the present study was to investigate the role of the histaminergic receptors H 1 and H 2 in cardiovascular responses to acute restraint stress. Wistar rats (280-320 g) received bilateral injections of cimetidine, mepyramine or saline into the MeA and were submitted to 45 min of restraint stress. Mepyramine microinjections at doses of 200, 100 and 50 nmol promoted a dose-dependent blockade of the hypertensive response induced by the restraint stress. Cimetidine (200 and 100 nmol) promoted a partial blockade of the hypertensive response to stress only at the highest dose administered. Neither drugs altered the typical stress-evoked tachycardiac responses. Furthermore, mepyramine and cimetidine were unable to modify the mean arterial pressure or heart rate of freely moving rats under basal conditions (non-stressed rats). The data suggest that in the MeA the histaminergic H 1 receptors appear to be more important than H 2 receptors in the hypertensive response to stress. Furthermore, there appears to be no histaminergic tonus in the MeA controlling blood pressure during non-stress conditions.
Introduction
Stress may be defined as a state of homeostatic imbalance that activates a cohort of behavioral, neuroendocrine and autonomic responses in order to restore the physiological balance of the organism. Chrousos proposed that responses to stressors could result in the reestablishment of basal homeostasis (eustasis) or in an inadequate return of homeostasis to basal level (allostasis) or in an enhanced homeostatic capacity (hyperstasis) [1] . Allostasis may be an insufficient or an excessive adaptive response to stress and is more harmful to the organism, resulting in pathological conditions.
With modern day lifestyles, stress contributes to both morbidity and mortality from chronic diseases [1] . Acute stress has been shown to account for a 1.38-fold greater risk of acute myocardial infarction and constitutes an important risk factor for hypertension [2] . According to the Global Brief on Hypertension published in 2013 by the World Health Organization, approximately 17 million deaths occur annually worldwide as a result of cardiovascular disease. In addition, according to that document, hypertension is responsible for at least 45% of deaths due to heart disease and 51% of deaths due to stroke [3] .
Brain histamine is involved in arousal, the sleep-wake cycle, appetite control, anxiety and memory [4] [5] [6] [7] [8] . Furthermore, histamine has been implicated in some pathological conditions such as schizophrenia, Alzheimer's disease, Parkinson's disease and Tourette's syndrome, and in addictive behavior [9] [10] [11] . Histamine seems to play a protective role against noxious stimuli such as pain, convulsion and stress. The release of brain histamine activates behavioral, autonomic and neuroendocrine responses, allowing the individual to cope with stress situations [5, 8, 12] . Indeed, several types of stressors are able to activate histaminergic neurons of the tuberomamillary nucleus (TMN) [4, 13] Furthermore, acute and chronic stress increases histamine turnover in different brain areas such as the hypothalamus, cortex, nucleus accumbens, striatum and midbrain [14] [15] [16] [17] . Histamine has been shown to mediate the release of neurotransmitters and stress-related hormones such as serotonin, noradrenaline, corticotrophin-releasing hormone, vasopressin and β-endorphin [5, 18, 19] . Based on these data, it has been suggested that histamine release could be used as an indicator of stress [4, 5] . However, the nature of the participation of histamine in the responses to stress is not completely understood. Different brain areas seem to be involved in the cardiovascular responses to stress, including the lateral and medial septal area, supraoptic nucleus, paraventricular nucleus (PVN), dorsomedial hypothalamus (DMH), the bed nucleus of the stria terminalis, amygdaloid nuclei, periaqueductal gray, locus ceruleus, the nucleus tractus solitarius (NTS) and the rostral ventrolateral medulla (RVLM) [10, 20, 21] . It is noteworthy that, of these areas, the amygdaloid complex is fundamental in processing emotions and is crucial in integrating the autonomic, neuroendocrine and behavioral responses to stressful conditions [22] . Both the central amygdala (CeA) and the medial amygdala (MeA) have been shown to participate in cardiovascular control [23, 24] . However, acute emotional stress activates the MeA to a greater extent than any of the other amygdaloid structures [25] [26] [27] . Lesions of the MeA have been shown to decrease cardiovascular response to restraint stress and attenuate the development of hypertension in spontaneously hypertensive rats [28, 29] .
The MeA has been shown to receive histaminergic projections from the TMN [30, 31] . Furthermore, microinjections of histamine in the MeA modulate the baroreflex, and analysis of the heart rate variability indicates a decrease in the vagal component of the baroreflex and an increase in the sympathetic/parasympathetic balance under basal conditions [32] . These data support the idea that histaminergic activity in the MeA may modulate cardiovascular responses. Although there are studies showing the participation of central histaminergic pathways in the control of blood pressure under a cardiovascular challenge such as hemorrhagic shock [33] , it is not known whether histaminergic systems directly regulate blood pressure under stress conditions. Therefore, the aim of the present study was to investigate the role of H 1 and H 2 receptors in the MeA in cardiovascular responses to stress. Since the MeA is involved in the behavioral and cardiovascular responses to stress and since the expression of histaminergic receptors in the MeA is dense [4, 5, 30, 34, 35] , our hypothesis is that histamine released in the MeA during stress may activate H 1 and H 2 receptors and this activation may be important for the cardiovascular response to restraint stress in rats.
Materials and methods

Animals
Adult male Wistar rats (280-300 g) were kept under controlled light (lights on from 6 AM to 7 PM) and temperature (22 ± 2°C) conditions with free access to tap water and laboratory chow (Nuvital Nutrientes Ltda., Curitiba, Brazil). All experiments were conducted between 7 AM and 11 AM. The experimental protocols were performed in accordance with the regulations for the care of laboratory animals and were approved by the institution's Animal Ethics Committee (CEUA-ICS-UFBA # 018/2011).
Surgical procedures
Cannulation of the MeA was performed under ketamine/xylazine (80/11.5 mg/kg i.p.) anesthesia. Five days before the experimental sessions, a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA) was used to implant a 15 mm, 22-gauge, stainless steel cannula. The following coordinates were used: anteroposterior = 2.5 mm behind the bregma; lateral = ± 3.4 mm; vertical 8.3 mm below the skull [36] . The animals were placed in the stereotaxic apparatus with their heads in the horizontal position. The cannulas were cemented to the skull bone with dental acrylic and an obturator (25-gauge) was placed to avoid obstruction. The day before the experimental sessions, a catheter (PE50) filled with heparinized saline solution (1000 U/ml) was inserted into the left carotid artery under ketamine/xylazine anesthesia, and exteriorized at the nape of the animal's neck to permit blood pressure recording. After both surgeries, the animals were treated with an antibiotic combination of penicillin and streptomycin (Pentabiótico, Fort Dodge Ltda., Brazil; 0.2 ml/rat i.m.) and with the analgesic/antiinflammatory agent, flunixin meglumine (2.5 mg/kg i.m.) and then housed in individual cages.
Drugs and microinjections
The following drugs were used: mepyramine maleate (N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-pyridin-2-ylethane-1,2-diamine) an H 1 histaminergic receptor antagonist/inverse agonist, and cimetidine, an H 2 histaminergic receptor antagonist [37] [38] [39] . Both were purchased from Sigma Co., St. Louis, MO, USA. All the drugs were dissolved in isotonic saline solution. The doses of mepyramine used here were based on previous studies conducted by this same group and on data published in the literature [40] [41] [42] [43] [44] . Central injections were given using a Hamilton microsyringe connected through polyethylene tubing to a 30-gauge injector that was 1 mm longer than the guide cannula. A total volume of 200 nl was slowly injected (60 s) and the injector remained in the guide cannula for an additional 60 s.
Blood pressure recording
At the beginning of the experiment, the arterial catheters were gently connected, with the unrestrained animals in their home cages. Arterial pressure was continuously monitored through the carotid catheter connected to a blood pressure transducer (World Precision Instruments) whose signal was amplified and digitally recorded by an analog-to-digital interface (AqDados -application for data acquisition, Lynx Tecnologia Eletrônica Ltda., São Paulo, Brazil, version 7.0) and recorded (1 kHz) on a microcomputer for later analysis. In all experimental sets, pulsatile blood pressure was recorded for 30 min prior to the administration of any drug (baseline blood pressure), with the animals undisturbed in their home cages in a quiet room, thus assuring the investigator that each animal had normal and stable blood pressure and heart rate. Mean arterial pressure was calculated from the systolic and diastolic pressure, while heart rate was determined from pulsatile blood pressure using the AcqKnowledge software program, version 3.5.7, developed by Biopac Systems, Inc., California, USA. Mean arterial pressure and heart rate values at the end of the stabilization period (30 min) were considered reference values from which the data used in the present study were calculated. Each data point on the graphs represents the mean ± SEM of a group of animals' data and each individual animal's data represents an average of 1-minute data taken every 5 min of recording.
Restraint stress
Restraint stress was induced by placing the animals for 45 min inside plastic (PVC) tubes specifically designed to restrict their movements without promoting any apparent signs of pain. The tubes were provided with multiple holes to facilitate heat dissipation and an anterior and posterior opening for the nose and tail. The arterial catheter exteriorized in the animal's neck was connected to the blood pressure transducer through a special aperture located in the upper part of the restraint tube. Table 1 summarizes the effect of restraint stress on mean arterial pressure and heart rate in rats receiving injections of saline solution into the MeA compared to non-stressed animals.
Experimental design
The participation of H 1 and H 2 histaminergic receptors in cardiovascular responses induced by restraint stress was investigated in different groups of animals receiving bilateral injections of mepyramine (50, 100 and 200 nmol), cimetidine (100 and 200 nmol) or saline (control) into the MeA. The histaminergic antagonists were administered 10 min prior to initiating the restraint stress (time 0), with the animals in their home cages. Pulsatile blood pressure was recorded for an additional 15 min following restraint stress (recovery period), also with the animals in their home cages. To evaluate whether H 1 and H 2 histaminergic receptors in the MeA could exert any tonic regulatory control on the blood pressure and heart rate of non-stressed rats, separate groups of animals received bilateral injections of saline solution (controls), 200 nmol of mepyramine or cimetidine into the MeA and their pulsatile blood pressure was recorded for 70 min.
Histological procedures
At the end of the experiments, the animals were anesthetized with sodium thiopental (40 mg/kg i.p.) and submitted to transcardiac perfusion with isotonic saline solution followed by 10% formalin. In addition, they received bilateral injections of Evans Blue dye into the MeA at a volume of 200 nl per side. The brains were then removed and fixed in 10% formalin. The specimens were frozen and cut into 40 μm sections. To confirm the injection sites in relation to the MeA, the slices were stained with cresyl violet and analyzed by light microscopy. (Fig. 1B) . In the present study, drug diffusion was not directly evaluated. We cannot exclude the possibility that the drugs may have diffused to the vicinity of the MeA. However, the data from the animals whose cannulas were located outside the MeA or in its vicinity show that the histaminergic antagonists exerted no statistically significant effect on the hypertensive response to stress. The data from the animals in which the injections were off target are summarized in Table 2 . Only the data from the animals in which the injections were located in the MeA were analyzed and taken into consideration in the analysis of the effects of the pharmacological agents on cardiovascular responses.
Statistical analysis
The data are presented as means ± standard error of the mean (SEM). Statistical analyses were performed using the GraphPad Prism software (GPAD, version 6.03, San Diego, USA). Mean arterial pressure and heart rate were analyzed separately using a mixed-model analysis of variance (ANOVA) with time as the within-subjects repeated measure and drug treatment as the between-subjects variables (not repeated). The Bonferroni post-hoc test was used to compare the effects of the drugs during each measurement period. Differences between the groups were considered statistically significant at p b 0.05. The comparison of the inhibitory effect of the blockade of H 1 and H 2 receptors at the MeA on the hypertensive response to restraint stress was analyzed in the middle of the period of restraint stress (25 min) using one-way ANOVA followed by the Bonferroni post-hoc test. Differences between the groups were considered statistically significant at p b 0.05.
Results
Restraint stress promotes a significant increase in blood pressure and heart rate in rats receiving bilateral injections of saline solution into the MeA compared to non-stressed rats receiving the same treatment ( Table 1) .
The blockade of H 1 receptors in the MeA reduces the hypertensive response to restraint stress in a dose-dependent way. As expected, an increase in blood pressure occurred in the control group that oscillated between 27 mm Hg and 22 mm Hg during the 45-minute period of restraint stress. In the group of animals receiving bilateral injections of mepyramine at the doses of 100 and 200 nmol into the MeA, the hypertensive response induced by the restraint stress was significantly inhibited. However, the inhibitory effect promoted by mepyramine at the dose of 100 nmol was less pronounced (alternating at around 16 and 13 mm Hg) compared to the dose of 200 nmol (12 to 4 mm Hg). The hypertensive response of the group treated with mepyramine at the dose of 50 nmol was similar to that of the control group. Prior to the initiation of restraint stress, the blood pressure of the animals in the mepyramine-treated groups, at all the doses used, was similar to that of the control group. During the recovery period following the end of restraint stress, blood pressure was similar in all the groups (Fig. 2A) . The tachycardic response induced by restraint stress remained unaltered by the blockade of H 1 receptors at the MeA (Fig. 2B) . The results of the mixed model ANOVA applied in this experimental set are shown in Table 3 .
The hypertensive response to restraint stress was partially inhibited by the blockade of H 2 receptors at the MeA. Blood pressure values during restraint stress in the group receiving 200 nmol of cimetidine were around 20 and 12 mm Hg, while blood pressure values in the control group alternated around 27 and 23 mm Hg. In the group of animals treated with 100 nmol of cimetidine, the hypertensive response was similar to that of the control group (oscillating at around 24 and 20 mm Hg). The blockade of H 2 receptors at the MeA did not alter blood pressure prior to restraint stress. During the recovery period, blood pressure was similar in all the groups (Fig. 3A) . The blockade of H 2 receptors at the MeA did not change the tachycardic response induced by restraint stress (Fig. 3B) . The results of the mixed model ANOVA applied in this experimental set are shown in Table 3 .
The inhibitory effect of the blockade of H 1 and H 2 receptors at the MeA on the hypertensive response induced by restraint stress was Table 1 Comparison of cardiovascular parameters between stressed and non-stressed rats that received microinjections of saline 0.9% in the MeA during the experimental period.
Time (min)
Non-stressed Rats Stressed Rats min. *The mixed-model analysis of variance (ANOVA) followed by the Bonferroni posthoc test showed significant differences when compared to the group of non-stressed rats p b 0.05. MeA = medial amygdala; MAP = mean arterial pressure; HR = heart rate.
compared in the middle of the restraint stress period (25 min). As expected, there was a significant increase in the blood pressure of the saline-treated animals submitted to restraint stress compared to the saline-treated non-stressed animals. At a dose of 100 nmol, mepyramine significantly attenuated the hypertensive response to restraint stress, while cimetidine given at the same dose failed to modify stress-induced hypertension. At the dose of 200 nmol, both histaminergic antagonists inhibited the hypertensive response to restraint stress. However, blood pressure in the group treated with mepyramine was significantly lower (7.2 ± 2.1 mm Hg) compared to that of the cimetidine-treated group (14.8 ± 1.4 mm Hg). Furthermore, blood pressure in the mepyramine-treated rats was similar to that of the saline-treated, non-stressed rats (Fig. 4) . The blockade of H 1 and H 2 receptors had no effect on the hypertensive response or on the tachycardic response to restraint stress when the histaminergic antagonists were injected into sites located outside the MeA (Table 2) .
Bilateral injections of cimetidine and mepyramine at the highest dose used (200 nmol) into the MeA of non-stressed rats had no effect on blood pressure or heart rate ( Fig. 5A and B) . The results of the mixed model ANOVA applied in this experimental set are shown in Table 3 . Basal values for MAP were 108.7 ± 2.0 mm Hg (saline group; n = 8), 107.3 ± 4.5 mm Hg (mepyramine group; n = 5) and 105.5 ± 1.9 mm Hg (cimetidine group; n = 6). Basal values for HR were 340.1 ± 9.38 bpm (saline group), 344.2 ± 10.2 bpm (mepyramine group) and 328.5 ± 5.5 bpm (cimetidine group). Mepyramine, cimetidine or saline were injected bilaterally into the MeA at −10 min; the restraint stress period started at time 0 and ended at 45 min. The mixed-model analysis of variance (ANOVA) followed by the Bonferroni post-hoc test showed no significant differences between groups at any parameter. MGP = medial globus pallidus; BMA = basomedial amygdala, anterior part; ACo = anterior cortical amygdaloid nucleus; and LH = lateral hypothalamus; MAP = mean arterial pressure; HR = heart rate.
Discussion
The present study investigated the role of H 1 and H 2 receptors in the MeA in relation to cardiovascular responses to stress. The brain histaminergic pathways originate in the TMN, which sends fiber projections in a diffuse manner to prosencephalic and rhombencephalic structures such as the septal area, preoptic area, suprachiasmatic nucleus, supraoptic nucleus, paraventricular nucleus, anterior hypothalamic area, the bed nucleus of the stria terminalis, the amygdaloid complex, nucleus of the solitary tract and the parabrachial nucleus [31, [45] [46] [47] . Recent studies using knockout mice and positron emission tomography in humans have clarified some of the functions of the brain histaminergic system [8] . The brain histaminergic system appears to be involved in different regulatory functions such as the sleep-wake cycle, arousal, anxiety, the release of hormones from the pituitary gland, antinociception, sodium and water balance and feeding behavior [5] . In addition, stimulation of the brain histaminergic system may modulate cardiovascular function [48] [49] [50] .
Four classes of histamine receptors have been identified: H 1 , H 2 , H 3 and H 4 . These are widely and diffusely distributed throughout the brain, with high to moderate expression in the hippocampus, hypothalamic nuclei, and amygdaloid complex [4, 5, 34, 35] . H 1 receptors are coupled to inositol phospholipid hydrolysis via G q/11 and H 2 receptors are positively coupled to adenylyl cyclase via G s protein, mediating an increase in cAMP. On the other hand, H 3 and H 4 are both coupled to G i protein, mediating a decrease in cAMP [4, 5, 34, 51] . In the amygdaloid complex, the MeA receives the densest afferent projections from the TMN, with a high density of H 1 receptors and a moderate density of H 2 receptors [4, 5, 30, 34, 35] . This characteristic suggests a functional role of histamine and its receptors in this area.
Different research groups have been investigating the brain neurotransmitters that participate in the control of autonomic nervous system activity and cardiovascular responses to stress. It has been shown that serotonin, noradrenaline, dopamine, vasopressin and angiotensin may be involved in these control mechanisms [1, 20, [52] [53] [54] [55] [56] . Among the brain areas involved in cardiovascular control during stress, the amygdaloid complex, particularly the MeA area, is important in regulating the cardiovascular responses associated with emotion [28, [57] [58] [59] . Although the MeA receives histaminergic projections from the TMN, has H 1 and H 2 receptors and is involved in the brain circuitry controlling emotional responses [60] , the role of histamine in the MeA on the control of cardiovascular responses to stress is unclear.
In the present study, the blockade of H 1 and H 2 receptors in the MeA reduced the hypertensive response to restraint stress in rats, although the inhibitory effect of the blockade of H 1 receptors was more intense than the blockade of H 2 receptors. The role of the brain histaminergic system in the response to stress has been described through the use of different research protocols. Several types of stressors increase the activity of histaminergic neurons in the TMN [4, 13, 48] and histamine turnover increases in different brain areas in both acute and chronic stress [17] . Indeed, there is depletion of histamine in the hypothalamus, thalamus, midbrain and cerebral cortex after 1 or 2 hours' exposure to restraint stress, extreme cold or the combination of both, indicating that these stressors may increase the use of histamine [12] . Our hypothesis is that histamine release in the MeA during stress may activate H 1 and H 2 receptors and this activation may be important for the hypertensive response to restraint stress in rats. Since the density of H 1 receptors is higher than that of the H 2 receptors in the MeA, this variation in receptor density may be partially responsible for the difference in the inhibitory response induced by the blockade of each of these histaminergic receptors in the MeA.
It has been demonstrated that different stressor stimuli activate selective neuronal circuitries, allowing the different types of stress (psychological and physical) to be categorized, and triggering the appropriate physiological response [61] . The MeA appears to constitute a crucial part of the brain circuitry involved in the adaptive responses to emotional stress, while the CeA participates in the responses to physical stress [62] . In rats submitted to restraint stress, a greater number of Fos positive cells are present in the MeA than in the CeA and there is an increase in Fos expression in the paraventricular and supraoptic nucleus [21, 26, 28, 60] . The MeA appears to be more important than the CeA in generating the neuroendocrine response to an unconditioned emotional stressor such as restraint [60, 62] and activation of the hypothalamic-pituitary axis during stress may depend on the functional integrity of the MeA [60, 63] . Restraint stress also activates catecholamine cell groups in the RVLM and this activation may be dependent on inputs from the MeA to the PVN that, in turn, sends efferent projections directly to the RVLM [64] .
In non-stressed animals, the histaminergic stimulation of the brain results in an increase in blood pressure and in sympathetic activity in rats [33, [48] [49] [50] . The hypertensive effect of central injections of histamine may be mediated by sympathetic activation [65] and the release of vasopressin, catecholamines and angiotensin II [48, 66, 67] . On the other hand, the results of the present study show that the blockade of H 1 and H 2 receptors in the MeA did not alter blood pressure in rats under non-stress conditions. This finding suggests that under nonstress conditions there is no histaminergic tonus in the MeA controlling blood pressure.
In addition to the hypertensive response induced by activation of the central histaminergic receptors, both bradycardia and tachycardia have been seen in non-stressed animals. Depending on the regions of the brain into which the histamine injections are given and the state of consciousness of the animal, the effects of histamine on heart rate may be diverse [44, 50] . Histamine injections into the PVN and anterior hypothalamus promote a tachycardic effect. A similar effect is also observed following the injection of H 1 receptor agonists into the NTS [66, 68] . On the other hand, injections of histamine into the intracerebroventricular system, RVLM and dorsal raphe nucleus induce a bradycardic effect [50, 69, 70] . In the present study, the blockade of H 1 and H 2 receptors in the MeA failed to alter heart rate, either in stressed or non-stressed animals. Some studies have suggested that the cardiac and vasomotor The mean arterial pressure and heart rate values were analyzed separately using a mixed-model analysis of variance (ANOVA) with one repeated measure factor (sixteen levels of time) and one group factor (drugs) not repeated. The post-hoc Bonferroni test was used to compare the effect of the drugs at each measurement time period, as shown in Figs. 2, 3 and 4. HR = heart rate; MAP = mean arterial pressure. The symbol * indicates statistically significant differences (mixed model design ANOVA followed by the Bonferroni post-hoc test) when drug-treated groups are compared to saline-treated controls. The symbol # indicates statistically significant differences when the group receiving cimetidine at the dose of 100 nmol was compared to the animals receiving cimetidine at the dose of 200 nmol. The letter "a" indicates statistically significant differences when stressed groups are compared to non-stressed, saline-treated animals. The letter "b" indicates statistically significant differences when stressed drug-treated groups are compared to stressed, saline-treated animals. The symbol * indicates statistically significant differences when the stressed cimetidine-treated group is compared to the stressed mepyramine-treated group (one-way ANOVA followed by the Bonferroni post-hoc test).
components may be separately controlled [71] . Efferent projections have been demonstrated from the MeA to the DMH [72, 73] , which in turn, may modulate vascular tonus via RVLM interplay and may control cardiac function through connections in the raphe/parapyramidal area [71, 74, 75] . The data found in the present study suggest that the histaminergic H 1 and H 2 receptors in the MeA may activate the descending pathway from the DMH controlling vascular tonus, but are possibly not involved in the cardiac function pathway modulating heart rate. Otherwise, connections from the MeA to the PVN, which sends direct projections to the RVLM, may be responsible for the increase in blood pressure during acute stress. Indeed, a moderate output from the MeA to the DMH has been demonstrated; nevertheless, there are dense projections to the bed nucleus of the stria terminalis, which in sequence send massive projections to the PVN [76] [77] [78] [79] . The blockade of the H 1 and H 2 receptors at the MeA disrupts this circuitry, hampering the hypertensive response to restraint stress but not the tachycardic response. Further studies should be conducted to confirm these hypotheses. In summary, the most intriguing finding of this study is that the blockade of histaminergic H 1 and H 2 receptors in the MeA impairs the hypertensive response to acute restraint stress without altering tachycardic response. Regarding the types of histaminergic receptors in the MeA, H 1 receptors appear to be more important than H 2 receptors in the hypertensive response to stress. Furthermore, there appears to be no histaminergic tonus in the MeA controlling blood pressure during non-stress conditions. Further studies are necessary to demonstrate the turnover of histamine in the MeA and the possible interaction of brain histaminergic pathways with other brain neurotransmitters controlling cardiovascular responses during stress.
